Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00724555 · ClinicalTrials.gov registry record

Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

A clinical trial of Stroke, sponsored by Georgetown University.

Completed
Registry status
2,005
Enrollment target
8
Study locations

NCT00724555 is a study of Stroke that has completed, run by Georgetown University. The registered enrollment target is 2,005 participants, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (83% lower). The trial reports 8 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00724555, a study of Stroke, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
2,005 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.

Conditions Studied

Stroke

Study Locations (8)

District of Columbia

  • Georgetown University, ASPIRE Coordinating Center - Washington D.C.
  • Washington Hospital Center - Washington D.C.
  • Sibley Memorial Hospital - Washington D.C.
  • Providence Hospital - Washington D.C.
  • United Medical Center (formerly known as Greater Southeast Community Hospital) - Washington D.C.
  • George Washington University Hospital - Washington D.C.
  • Howard University Hospital - Washington D.C.

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 2,005 participants
Start Date 2008-02
Est. Completion 2013-01

Sponsor

Georgetown University

227 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00724555

The ClinicalTrials.gov registry entry for NCT00724555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,005 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (83% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00724555 reports 8 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, New York.

Frequently Asked Questions

What is clinical trial NCT00724555 about?

NCT00724555 is a clinical study titled "Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities". The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.

What is the current status of trial NCT00724555?

This trial is currently completed. The enrollment target is 2,005 participants. The study started on 2008-02. Estimated completion is 2013-01.

What conditions does trial NCT00724555 study?

This clinical trial studies the following conditions: Stroke.

Who is sponsoring clinical trial NCT00724555?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00724555 being conducted?

This trial has 8 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.